INS and polycystic ovary syndrome: They demonstrated that the HOMA index was improved in all treatment groups, but when MYO was administered alone, it was able to reduce the insulin response only in obese PCOS patients without familial diabetes, where ALA, alone or plus MYO, was instead able to significantly decrease the insulin response, independently of the presence of diabetes.